561 related articles for article (PubMed ID: 16481071)
1. Common mechanisms of amyloid oligomer pathogenesis in degenerative disease.
Glabe CG
Neurobiol Aging; 2006 Apr; 27(4):570-5. PubMed ID: 16481071
[TBL] [Abstract][Full Text] [Related]
2. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
Meredith SC
Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
[TBL] [Abstract][Full Text] [Related]
3. Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis.
Glabe CG; Kayed R
Neurology; 2006 Jan; 66(2 Suppl 1):S74-8. PubMed ID: 16432151
[TBL] [Abstract][Full Text] [Related]
4. Conformation-dependent anti-amyloid oligomer antibodies.
Kayed R; Glabe CG
Methods Enzymol; 2006; 413():326-44. PubMed ID: 17046404
[TBL] [Abstract][Full Text] [Related]
5. Amyloid peptides and proteins in review.
Harrison RS; Sharpe PC; Singh Y; Fairlie DP
Rev Physiol Biochem Pharmacol; 2007; 159():1-77. PubMed ID: 17846922
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneous amyloid-formed ion channels as a common cytotoxic mechanism: implications for therapeutic strategies against amyloidosis.
Kourie JI; Culverson AL; Farrelly PV; Henry CL; Laohachai KN
Cell Biochem Biophys; 2002; 36(2-3):191-207. PubMed ID: 12139405
[TBL] [Abstract][Full Text] [Related]
7. Fibrils with parallel in-register structure constitute a major class of amyloid fibrils: molecular insights from electron paramagnetic resonance spectroscopy.
Margittai M; Langen R
Q Rev Biophys; 2008; 41(3-4):265-97. PubMed ID: 19079806
[TBL] [Abstract][Full Text] [Related]
8. Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases.
Ferreira ST; Vieira MN; De Felice FG
IUBMB Life; 2007; 59(4-5):332-45. PubMed ID: 17505973
[TBL] [Abstract][Full Text] [Related]
9. Poloxamer 188 copolymer membrane sealant rescues toxicity of amyloid oligomers in vitro.
Mina EW; Lasagna-Reeves C; Glabe CG; Kayed R
J Mol Biol; 2009 Aug; 391(3):577-85. PubMed ID: 19524592
[TBL] [Abstract][Full Text] [Related]
10. Fitting neurological protein aggregation kinetic data via a 2-step, minimal/"Ockham's razor" model: the Finke-Watzky mechanism of nucleation followed by autocatalytic surface growth.
Morris AM; Watzky MA; Agar JN; Finke RG
Biochemistry; 2008 Feb; 47(8):2413-27. PubMed ID: 18247636
[TBL] [Abstract][Full Text] [Related]
11. Protein-misfolding diseases and chaperone-based therapeutic approaches.
Chaudhuri TK; Paul S
FEBS J; 2006 Apr; 273(7):1331-49. PubMed ID: 16689923
[TBL] [Abstract][Full Text] [Related]
12. Linker histone H1 binds to disease associated amyloid-like fibrils.
Duce JA; Smith DP; Blake RE; Crouch PJ; Li QX; Masters CL; Trounce IA
J Mol Biol; 2006 Aug; 361(3):493-505. PubMed ID: 16854430
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationship of amyloid fibrils.
Maji SK; Wang L; Greenwald J; Riek R
FEBS Lett; 2009 Aug; 583(16):2610-7. PubMed ID: 19596006
[TBL] [Abstract][Full Text] [Related]
14. Structure of beta-amyloid fibrils and its relevance to their neurotoxicity: implications for the pathogenesis of Alzheimer's disease.
Irie K; Murakami K; Masuda Y; Morimoto A; Ohigashi H; Ohashi R; Takegoshi K; Nagao M; Shimizu T; Shirasawa T
J Biosci Bioeng; 2005 May; 99(5):437-47. PubMed ID: 16233815
[TBL] [Abstract][Full Text] [Related]
15. Directing the secondary structure of polypeptides at will: from helices to amyloids and back again?
Pagel K; Vagt T; Koksch B
Org Biomol Chem; 2005 Nov; 3(21):3843-50. PubMed ID: 16239998
[TBL] [Abstract][Full Text] [Related]
16. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL
Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231
[TBL] [Abstract][Full Text] [Related]
17. Soluble amyloid beta oligomers may contribute to apoptosis of retinal ganglion cells in glaucoma.
Yin H; Chen L; Chen X; Liu X
Med Hypotheses; 2008; 71(1):77-80. PubMed ID: 18406539
[TBL] [Abstract][Full Text] [Related]
18. Metal-dependent generation of reactive oxygen species from amyloid proteins implicated in neurodegenerative disease.
Allsop D; Mayes J; Moore S; Masad A; Tabner BJ
Biochem Soc Trans; 2008 Dec; 36(Pt 6):1293-8. PubMed ID: 19021543
[TBL] [Abstract][Full Text] [Related]
19. Interpreting the aggregation kinetics of amyloid peptides.
Pellarin R; Caflisch A
J Mol Biol; 2006 Jul; 360(4):882-92. PubMed ID: 16797587
[TBL] [Abstract][Full Text] [Related]
20. Protein misfolding in neurodegenerative diseases.
Agorogiannis EI; Agorogiannis GI; Papadimitriou A; Hadjigeorgiou GM
Neuropathol Appl Neurobiol; 2004 Jun; 30(3):215-24. PubMed ID: 15175075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
